[79 Pages Report] The US surgical procedures market is projected to reach 122,881.5 thousand procedures by 2027 from 105,814.5 thousand procedures in 2022, at a CAGR of 3.0% during the forecast period. The growth of this market is mainly attributed to the growing prevalence of cancer, growth in geriatric population, rise in chronic diseases, and technological advancements in surgical procedures. On the other hand, stringent regulations and the high cost of medical devices and shortage of surgeons is expected to restrain the growth of this market. With an aging US population and an increase in the incidence of chronic disease, patients will require more surgical procedures over their lifetime. The increasing life span of the US population is also boosting the need for surgical procedures. While the demand for surgeons is steadily increasing, the supply of future surgeons is not rising at the same rate. Therefore, this shortage is likely to reduce the number of surgeries performed per year.
To know about the assumptions considered for the study, Request for Free Sample Report
The increased pressure due to the growing rate of hospitalization of COVID-19 patients led to the re-profiling of many hospitals and departments for treating patients with COVID-19.
The provision of cardiac surgeries has been disproportionally affected due to the reallocation of intensive care resources. According to a comprehensive analysis of a Society of Thoracic Surgeons (STS) database, cardiac surgery volumes in the US fell by more than half during the COVID-19 pandemic’s first wave. Cardiac surgery services have undergone structural remodeling into a centralized system to continue provisions of emergency surgery alongside hospital management of COVID-19 patients. Although these measures have been beneficial for supporting the focused management of COVID-19 patients, it is important to reflect upon the future consequences of delayed elective cardiac surgery. Patients with cardiac complications are likely to have progressive conditions.
On the other hand, the pandemic has also resulted in disruptions in the supply chain, affecting the global medical devices industry. The pandemic has adversely impacted global financial expectations, supply chain, operations, and crisis response plans. The manufacturers of surgical instruments faced the heat of the disruptions owing to the spread of COVID-19, leading to lockdowns and travel restrictions. The manufacturing of medical devices such as surgical instruments was significantly affected as major economies were severely affected due to the spread of COVID-19 infections.
Surgery is a fundamental modality for the curative and palliative treatment of most cancers in countries across all income settings. In high-income countries (HICs) like the US, where the most common solid organ malignant cancers, such as breast & colon cancers, are more likely to be successfully diagnosed at early stages, surgical resection provides definitive locoregional control of the primary tumor. When combined with appropriately selected adjuvant systemic treatment and radiotherapy, this approach has significant curative potential.
In 2021, an estimated 1.9 million new cancer cases were diagnosed in the US, and 608,570 people will die from the disease—up from 1.8 million new cancer cases and 606,520 cancer deaths in 2020 (Source: American Cancer Society). The most common cancers are breast cancer, lung & bronchus cancer, prostate cancer, colon & rectum cancer, bladder cancer, and kidney & renal pelvis cancer. Prostate, lung, and colorectal cancers account for an estimated 43% of all cancers diagnosed in men in 2020. For women, the three most common cancers are breast, lung, and colorectal, and they will account for an estimated 50% of all new cancer diagnoses in women in 2020 (Source: National Cancer Institute). The removal of cancerous tissue using surgery is the preferred treatment choice in the case of solid tumors contained in one area.
The growth in the geriatric population increases the burden on the medical system. Older individuals require more medical services and care as compared to younger counterparts. There will be increased demand for surgeons and a perioperative workforce with competency in senior care. The US is already experiencing shortages in nine of ten surgical specialties, with orthopedic surgery, general surgery, and urology having the largest surgeon deficits for specialties performing major surgery.
A 2019 Association of American Medical Colleges (AAMC) report predicted a shortage of 23,000 surgeons in 2032 and 28,700 by 2033 in the US. This projected shortfall range is based on a model that accounts for population projections, demand & supply projections, estimates of physician specialty choice, recently revised federal health professional shortage area designations for primary care and mental health, and lower projections of future insurance coverage expansion. More than two of every five active physicians in the US will reach 65 or older within ten years; such factors within the US population drive the need for more healthcare workers. For example, from 2019 to 2031, the population is projected to grow by 10.6%, increasing 42.4% of those aged 65 and above.
Outpatient surgery, also known as ambulatory surgery, day surgery, day case surgery, or same-day surgery, is surgery that does not require an overnight hospital stay. The term outpatient means patients may enter and leave the facility on the same day. The advantages of outpatient surgery over inpatient surgery include greater convenience and reduced costs. Common procedures that are often done on an outpatient basis include:
Medical procedures are moving into outpatient facilities due to technological advances such as minimally invasive surgical procedures and value-based care incentives. Health plans and government program payment policies support providing services in lower-cost care settings, including outpatient facilities. Health systems have also been acquiring or partnering with physicians and physician practices, further driving the volume of services performed in outpatient settings.
Surgical errors are a serious public health problem and a leading cause of death in the US. Medical errors are a leading cause of injury and avoidable harm in health care systems. Globally, the cost associated with medication errors has been estimated at USD 42 billion annually, and unsafe surgical care procedures cause complications in up to 25% of patients. According to NCBI, at least 4000 surgical errors occur each year in the US. Some of the causes of surgical errors include the following:
Market size available for years
Base year considered
Volume (Thousand Procedures)
By type and By Channel
The study categorizes the US Surgical Procedures Market based on type and channel.
Note: Other surgical procedures include procedures targeting the nervous system, the endocrine system, and the integumentary system.
While wrong site/wrong procedure surgery continues to be the most common basis for quality-of-care violations, cancer-related issues, neurological issues, cardiac-related issues, timely responding to complications during surgery and post-operatively, and urological-related issues have been determined as the most misdiagnosed conditions. It is challenging to uncover a consistent cause of errors and, even if found, provide a consistent, viable solution that minimizes the chances of a recurrent event.
What are technological advancements in the surgical procedures in the US?
In recent years, the advancement of computational and automated technologies has helped surgeons and medical specialists in the operating room such as, 3D high-definition endoscope with a rotating tip named MARVEL (Multi-Angle Rear-Viewing Endoscopic tool), virtual reality, electrosurgical instruments and smart glasses.
What are emerging trends in the US surgical prcoedures market?
One of the major advances in recent years is minimally invasive surgical techniques that use small incisions, precision tools, and advanced imaging technology. This allows patients to undergo surgery in a single day and not require an overnight stay in the hospital for monitoring. In minimally invasive surgery (MIS), doctors use various techniques to operate with less damage to the body than with open surgery. MIS is associated with less pain, shorter hospital stays, and fewer complications.
Which segment of type is estimated to grow at the highest CAGR during the forecast period?
The ophthalmic surgical procedures segment is estimated to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the prevalence of various ophthalmic disorders such as glaucoma, cataract, and diabetic retinopathy rise in the geriatric population and the associated increase in eye diseases due to longer screen time. Ophthalmic surgery treats various conditions, including cataracts, glaucoma, detached retinas, retinal tears, diabetic retinopathy, and nearsightedness or farsightedness.
Which segment of hospitals is estimated to grow at the highest CAGR during the forecast period?
The outpatient surgeries segment is estimated to grow at the highest CAGR during the forecast period. in 2021. Growth in the outpatient surgeries segment is attributed to factors such as lower cost, low waiting time, and convenience.
Which segment has the second largest share of the US Surgical Procedures Market?
In 2021, orthopedic surgical procedures has the second largest share of the US surgical procedures market. Market growth is attributed to the rising prevalence of orthopedic disorders, increasing incidence of sports & traumatic injuries, and availability of technologically advanced orthopedic devices. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 11)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 SCOPE OF THE STUDY
1.3.1 MARKETS COVERED
FIGURE 1 US OUTPATIENT SURGICAL PROCEDURES MARKET
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 14)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
188.8.131.52 Key data from secondary sources
2.1.2 PRIMARY DATA
184.108.40.206 Key data from primary sources
220.127.116.11 Key industry insights
2.2 MARKET ESTIMATION
FIGURE 3 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE US SURGICAL PROCEDURES MARKET (2022–2027)
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 4 MARKET DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS FOR THE STUDY
2.5 METHODOLOGY-RELATED LIMITATIONS
3 EXECUTIVE SUMMARY (Page No. - 21)
FIGURE 5 US SURGICAL PROCEDURES MARKET, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES)
FIGURE 6 GASTROINTESTINAL SURGICAL PROCEDURES, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES)
FIGURE 7 CARDIOVASCULAR SURGICAL PROCEDURES, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES)
FIGURE 8 DENTAL SURGICAL PROCEDURES, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES)
FIGURE 9 COSMETIC SURGICAL PROCEDURES, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES)
FIGURE 10 UROLOGIC SURGICAL PROCEDURES, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES)
FIGURE 11 OPHTHALMIC SURGICAL PROCEDURES, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES)
FIGURE 12 ORTHOPEDIC SURGICAL PROCEDURES, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES)
FIGURE 13 ENT SURGICAL PROCEDURES MARKET, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES)
FIGURE 14 OBSTETRIC/ GYNECOLOGIC SURGICAL PROCEDURES MARKET, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES)
FIGURE 15 US SURGICAL PROCEDURES MARKET, BY CHANNEL, 2022 VS. 2027 (THOUSAND PROCEDURES)
4 PREMIUM INSIGHTS (Page No. - 28)
4.1 US SURGICAL PROCEDURES MARKET OVERVIEW
FIGURE 16 GROWTH IN GERIATRIC POPULATION AND RISE IN CHRONIC DISEASES TO DRIVE MARKET GROWTH
4.2 US SURGICAL PROCEDURES MARKET, BY TYPE
FIGURE 17 DENTAL SURGICAL PROCEDURES SEGMENT TO HOLD THE LARGEST SHARE OF THE US SURGICAL PROCEDURES MARKET IN 2021
5 MARKET OVERVIEW (Page No. - 30)
5.2 MARKET DYNAMICS
FIGURE 18 US SURGICAL PROCEDURES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
18.104.22.168 Growing prevalence of cancer requiring surgical treatment
FIGURE 19 US: CANCER CASES, BY TYPE, 2020–2040 (THOUSANDS)
FIGURE 20 US: NEW CANCER CASES, 2012–2022 (MILLION INDIVIDUALS)
22.214.171.124 Growth in geriatric population and rise in chronic diseases
FIGURE 21 US: NUMBER OF PEOPLE WITH CHRONIC CONDITIONS, 1995–2030 (MILLION)
126.96.36.199 Technological advancements in surgical procedures
TABLE 1 US: RISE IN SURGICAL PROCEDURES
FIGURE 22 US: R&D INVESTMENTS IN MEDICAL TECHNOLOGY, 2013-2018 (MILLION)
188.8.131.52 Shortage of surgeons
184.108.40.206 Increasing adoption of outpatient surgeries
220.127.116.11 Surgical errors
18.104.22.168 Complications associated with surgical procedures
TABLE 2 COMPLICATIONS ASSOCIATED WITH SURGICAL PROCEDURES
6 INDUSTRY INSIGHTS (Page No. - 40)
6.2 INDUSTRY TRENDS
6.2.1 MINIMALLY INVASIVE SURGERY
6.2.2 INCREASING ADOPTION OF ADVANCED ROBOTICS IN ASCS
6.3 REIMBURSEMENT SCENARIO
TABLE 3 LIST OF SURGICAL PROCEDURE CODES
6.4 IMPACT OF COVID-19 ON THE US SURGICAL PROCEDURES MARKET
6.5 TECHNOLOGY ANALYSIS
7 US SURGICAL PROCEDURES MARKET, BY TYPE (Page No. - 46)
TABLE 4 US: SURGICAL PROCEDURES MARKET, BY TYPE, 2020–2027 (THOUSAND)
7.2 DENTAL SURGICAL PROCEDURES
7.2.1 INCREASING PREVALENCE OF ORAL DISEASES AND RISING AWARENESS OF DENTAL CARE DRIVE THE GROWTH OF DENTAL SURGICAL PROCEDURES
TABLE 5 US: DENTAL SURGICAL PROCEDURES, BY TYPE, 2020-2027 (THOUSAND)
7.3 ORTHOPEDIC SURGICAL PROCEDURES
7.3.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED ORTHOPEDIC DEVICES WILL INCREASE THE NUMBER OF ORTHOPEDIC SURGICAL PROCEDURES
TABLE 6 US: ORTHOPEDIC SURGICAL PROCEDURES, BY TYPE, 2020-2027 (THOUSAND)
7.4 GASTROINTESTINAL SURGICAL PROCEDURES
7.4.1 THE INCREASING NUMBER OF GASTROINTESTINAL CANCER CASES IS DRIVING GROWTH IN THIS SEGMENT
FIGURE 23 US: STOMACH CANCER INCIDENCE, 2020–2040 (THOUSANDS)
TABLE 7 US: GASTROINTESTINAL SURGICAL PROCEDURES, BY TYPE, 2020-2027 (THOUSAND)
7.5 OPHTHALMIC SURGICAL PROCEDURES
7.5.1 RISING PREVALENCE OF GLAUCOMA, CATARACT, AND DIABETIC RETINOPATHY DRIVE DEMAND FOR OPHTHALMIC SURGICAL TREATMENT IN THE US
TABLE 8 US: OPHTHALMIC SURGICAL PROCEDURES, BY TYPE, 2020-2027 (THOUSAND)
7.6 CARDIOVASCULAR SURGICAL PROCEDURES
7.6.1 HEART DISEASE IS THE LEADING CAUSE OF DEATH IN THE US
TABLE 9 US: NUMBER OF CASES OF CARDIOVASCULAR DISEASES, 2015-2035 (MILLION)
FIGURE 24 US: MORTALITY RATE OF CARDIOVASCULAR DISEASES, BY TYPE, 2018
TABLE 10 US: CARDIOVASCULAR SURGICAL PROCEDURES, BY TYPE, 2020-2027 (THOUSAND)
7.7 OBSTETRIC/GYNECOLOGIC SURGICAL PROCEDURES
7.7.1 INCREASING INCIDENCE OF GYNECOLOGICAL DISEASES DRIVES MARKET GROWTH
TABLE 11 US: OBSTETRIC/GYNECOLOGIC SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND)
7.8 ENT SURGICAL PROCEDURES
7.8.1 RISING DISPOSABLE INCOME AND INCREASING AFFORDABILITY ARE MAJOR REASONS FOR THE GROWTH OF ENT SURGICAL PROCEDURES
TABLE 12 US: ENT SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND)
7.9 COSMETIC SURGICAL PROCEDURES
7.9.1 ADVENT OF MINIMALLY INVASIVE SURGICAL PROCEDURES BOOSTS THE ADOPTION OF COSMETIC SURGERIES
TABLE 13 US: COSMETIC SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND)
7.10 UROLOGIC SURGICAL PROCEDURES
7.10.1 INCREASING INCIDENCE OF DIABETES AND HIGH BLOOD PRESSURE INCREASES THE RISK OF KIDNEY DISEASES
TABLE 14 US: UROLOGIC SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND)
7.11 OTHER SURGICAL PROCEDURES
TABLE 15 US: NERVOUS SYSTEM SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND)
TABLE 16 US: ENDOCRINE SYSTEM SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND)
TABLE 17 US: INTEGUMENTARY SYSTEM SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND)
8 US SURGICAL PROCEDURES MARKET, BY CHANNEL (Page No. - 64)
TABLE 18 US SURGICAL PROCEDURES MARKET, BY CHANNEL, 2020–2027 (THOUSAND)
8.2 PHYSICIAN OFFICES
8.2.1 TECHNOLOGICAL ADVANCES MAKING OFFICE-BASED SURGERY MORE FEASIBLE DRIVE THE MARKET GROWTH
TABLE 19 US: NUMBER OF REGISTERED HOSPITALS, BY NUMBER OF BEDS (2019)
TABLE 20 US SURGICAL PROCEDURES MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (THOUSAND)
8.3.1 INPATIENT SURGERIES
22.214.171.124 Increasing incidences of cardiovascular, neurological, and intestinal disorders are driving growth for this market
FIGURE 25 US NATIONAL INPATIENT STAYS, 2016–2018
8.3.2 OUTPATIENT SURGERIES
126.96.36.199 Convenience and lower cost are major advantages of outpatient surgeries
8.4 AMBULATORY SURGERY CENTERS
8.4.1 LOWER COSTS AND SHORTER PATIENT STAYS PROPEL THE GROWTH OF THIS SEGMENT
9 APPENDIX (Page No. - 71)
9.1 DISCUSSION GUIDE
9.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
9.3 RELATED REPORTS
9.4 AUTHOR DETAILS
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, and key market dynamics.
This research study involved the usage of widespread secondary sources; directories; databases such as Hoover’s, Bloomberg Business, Factiva, and Avention; and white papers. Secondary research was used to identify and collect information for the extensive, technical, market-oriented, and commercial study of the US surgical procedures market. It was also used to obtain important information about market classification and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various participants from the US were interviewed to obtain qualitative and quantitative information for this report. Primary sources included doctors, plastic surgeons, dental surgeons, nurses, radiologists, cardiac surgeons, physicians, medical residents, physician assistants, and medical information officers. This primary data was collected through questionnaires, e-mails, and telephonic interviews.
The total number of US surgical procedures was arrived at after data triangulation from the different approaches, as mentioned below.
After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The following figure shows the market validation, source structure, and data triangulation methodology implemented in the market engineering process.